Cargando…
A rapid test recognizing mucosal SARS-CoV-2-specific antibodies distinguishes prodromal from convalescent COVID-19
The COVID-19 pandemic poses enormous challenges to global healthcare sectors. To prevent the overburden of medical systems, it is crucial to distinguish individuals approaching the most infectious early phase from those in the declining non-infectious phase. However, a large fraction of transmission...
Autores principales: | Krempe, Friederike, Schöler, Lara, Katschinski, Benjamin, Herrmann, Anke, Anastasiou, Olympia E., Elsner, Carina, Ross, R. Stefan, Scholz, Friedrich, Dittmer, Ulf, Miethe, Peter, Le-Trilling, Vu Thuy Khanh, Trilling, Mirko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8481626/ https://www.ncbi.nlm.nih.gov/pubmed/34608451 http://dx.doi.org/10.1016/j.isci.2021.103194 |
Ejemplares similares
-
A Novel In-Cell ELISA Assay Allows Rapid and Automated Quantification of SARS-CoV-2 to Analyze Neutralizing Antibodies and Antiviral Compounds
por: Schöler, Lara, et al.
Publicado: (2020) -
Over 90% of clinical swabs used for SARS‐CoV‐2 diagnostics contain sufficient nucleic acid concentrations
por: Klingen, Robin L., et al.
Publicado: (2021) -
A simple algorithm based on initial Ct values predicts the duration to SARS-CoV-2 negativity and allows more efficient test-to-release and return-to-work schedules
por: Anastasiou, Olympia E., et al.
Publicado: (2023) -
Antibody responses elicited by mRNA vaccination in firefighters persist six months and correlate inversely with age and directly with BMI
por: Holtkamp, Caroline, et al.
Publicado: (2022) -
Establishment and clinical validation of an in-cell-ELISA-based assay for the rapid quantification of Rabies lyssavirus neutralizing antibodies
por: Schöler, Lara, et al.
Publicado: (2022)